ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,453 | +2.6% | 9,151 | +27.9% | 0.00% | – |
Q2 2023 | $26,754 | +115.8% | 7,154 | +93.3% | 0.00% | – |
Q1 2023 | $12,397 | -34.8% | 3,701 | -1.9% | 0.00% | – |
Q4 2022 | $19,000 | -20.8% | 3,771 | -10.0% | 0.00% | – |
Q3 2022 | $24,000 | -17.2% | 4,192 | 0.0% | 0.00% | – |
Q2 2022 | $29,000 | +3.6% | 4,192 | +3.0% | 0.00% | – |
Q1 2022 | $28,000 | +40.0% | 4,070 | +78.8% | 0.00% | – |
Q4 2021 | $20,000 | +81.8% | 2,276 | +598.2% | 0.00% | – |
Q3 2021 | $11,000 | +175.0% | 326 | +85.2% | 0.00% | – |
Q2 2021 | $4,000 | – | 176 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
Atom Investors LP | 30,911 | $219,000 | 0.10% |
FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |